Pay in 4 interest-free payments of $5.42 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Follow-up clinical trials among humans found mixed results
In addition to ocular surface outcomes, clinical and biochemical characteristics were considered to contextualize our findings
It enhances insulin secretion in response to meals, inhibits glucagon release (which helps prevent the liver from producing too much glucose), and promotes satiety, reducing food intake
Additional Blog Posts Innovations in Care for Type 1 Diabetes: Tzield Tzield (teplizumab) is now available at Lurie Children's to help preserve insulin production in kids newly diagnosed with type 1 diabetes
US$ 29.95
US$ 29.44
US$ 22.31
US$ 23.94
US$ 25.53
US$ 27.77
